⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for childhood acute minimally differentiated myeloid leukemia (m0)

Every month we try and update this database with for childhood acute minimally differentiated myeloid leukemia (m0) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531NCT01407757
Leukemia
DNA analysis
gene expression...
laboratory biom...
pharmacogenomic...
- 29 YearsChildren's Oncology Group
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerNCT00003661
Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 YearsRoswell Park Cancer Institute
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous LeukemiaNCT00003758
Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 YearsNational Cancer Institute (NCI)
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid LeukemiaNCT01321385
Leukemia
laboratory biom...
study of socioe...
- 21 YearsChildren's Oncology Group
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerNCT00003661
Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 YearsRoswell Park Cancer Institute
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaNCT00006363
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 YearsNational Cancer Institute (NCI)
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid LeukemiaNCT01076569
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Child...
Untreated Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid LeukemiaNCT00666588
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Adult...
Recurrent Child...
Secondary Acute...
idarubicin
cytarabine
bortezomib
etoposide
laboratory biom...
1 Year - 21 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaNCT00004056
Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
melphalan
thioguanine
peripheral bloo...
- 21 YearsChildren's Oncology Group
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01146210
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Fanconi Anemia
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Chemotherapy in Treating Children With Recurrent Acute Myeloid LeukemiaNCT00003178
Leukemia
filgrastim
cladribine
idarubicin
- 21 YearsChildren's Oncology Group
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyNCT00070174
Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT00372593
Leukemia
asparaginase
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
mitoxantrone hy...
- 29 YearsChildren's Oncology Group
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification TherapyNCT00070174
Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous LeukemiaNCT00003758
Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaNCT00006363
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 YearsNational Cancer Institute (NCI)
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeNCT00005593
Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid LeukemiaNCT01438138
Leukemia
diagnostic labo...
- 21 YearsChildren's Oncology Group
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid LeukemiaNCT01438138
Leukemia
diagnostic labo...
- 21 YearsChildren's Oncology Group
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid LeukemiaNCT01076569
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Child...
Untreated Child...
laboratory biom...
- 21 YearsChildren's Oncology Group
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid LeukemiaNCT01321385
Leukemia
laboratory biom...
study of socioe...
- 21 YearsChildren's Oncology Group
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeNCT00005593
Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: